Shamis & Gentile, P.A. is investigating claims on behalf of investors of 3M Company (“3M” or the “Company”) (MMM) in connection with the Neogen Corporation (“Neogen”) transaction. Impacted investors are advised to contact the firm now.
In September 2022, Neogen completed a merger with 3M’s Food Safety business. As part of the deal, 3M stockholders who tendered shares received approximately 6.8 shares of Neogen common stock for each share of 3M common stock.
The investigation concerns whether the merger proxy materials contain false and misleading and/or failed to disclose critical information about the Neogen’s financial health and operations. Neogen’s stock price has declined by 75% since September 1, 2022, the date upon which Neogen issued shares to former or current 3M investors,
Shamis & Gentile, P.A. stands out as an advocate for investors who are victims of securities fraud. The firm is committed to securing recoveries for investors who have incurred damages due to false and misleading statements or other corporate misconduct by public companies.
Shamis Gentile has recovered over $1 billion for consumers nationwide. Its extensive experience, expertise, and resources enable the firm to resolve disputes in a wide range of matters, including class actions, mass torts and mass arbitrations.
